Redeye reduces its sales forecasts for Q2 2023, mainly as we adjust our estimates to Fortnox’s current ARR definition, negatively affecting the short-term Core Subscription growth forecasts. However, the Base Case remains unchanged, and the effect on our 2024 forecasts is minor.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments

Fortnox Q2 2023 - Preview

© Modular Finance, source Nordic Press Releases